SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert DeHaven who wrote (408)5/11/1998 10:20:00 PM
From: Manny Gugliuzza   of 1510
 
and do not forget about gruntal & co. with david saks are still aggressively following in their morning notes on a regular basis about Imnrs potential blockbuster drug-REMUNE.

i think it was Dec. they upgraded the stock and have been regular with research reports, $10. each, nearly 2x a month.

strong bids and good support intraday on pulls backs may just have to dive into those 15's at the market.

ar.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News